KBI Biopharma
Andrew Duncan is a Senior Research Associate at KBI Biopharma, with extensive experience in technical development projects aimed at enhancing analytical methods and purification processes. Previous roles include Research Associate II at Asklepios BioPharmaceutical, Inc., where contributions to molecular biology assay development were made in compliance with FDA and ICH guidelines. Andrew also served as a Laboratory Teaching Assistant at NC State University, leading experiments and short courses in virus biotechnology and metagenomics. The academic background includes a Master’s degree in Biochemistry and a Bachelor’s degree in Biology with a concentration in Human Biology from North Carolina State University, complemented by a certification in Biotechnology.
KBI Biopharma
6 followers
KBI Biopharma is a Global Contract Development & Manufacturing Organization (CDMO|CMO) offering Cell Line Development, Process Analytical & Formulation Development, Clinical & Commercial Manufacturing, Characterization & Cell Therapy services.